Stem cell therapy treats animal ailments, vets see improvement Stem cell therapy is typically tied to controversy but now, some Southern Arizona veterinarians are turning to a different form of the cutting edge treatment... By: kgun9 … Continue reading →

HUMAN nature has it that when there is something new, be it related to food, enhancements to ones appearance, and even in ones search for answers and treatments to an illness, one may be most willing to brave and enter that unknown territory. I had the privilege of meeting a very remarkable woman, diagnosed with the Big C of the liver, who, in her desire to prolong her days, agreed to go through stem cell therapy. In the course of our conversation, I realized that, patients must be given the correct information, and should be armed with the necessary knowledge of the treatment modalities, including success and failure rates, complications, cost and expectations. This applies not only to what is new, but, even in the most tested of treatment options, patients have the right to know and understand. Stem cell therapy is one breakthrough in Medical Science. It shows a lot of promise and potential in treating diseases. Stem cell therapy is an intervention strategy where new adult stem cells are introduced into damaged or diseased tissues, in order to treat the disease or injury. These cells are present during the early stages of life and have the remarkable potential … Continue reading →

DAVAO CITY The Department of Health is set to conduct a surveillance of all establishments in the Davao Region that are offering stem cell treatments without the proper authorization. At present there are no facilities in the Region that have been authorized by DOH to perform stem cell treatments, DOH 11 Licensing Officer Alex F. Daba said. He said so far two clinics located in the city have applied for authorization. The move is in accordance with Administrative Order 2013-0012 providing the Rules and Regulations Governing the Accreditation of Health Facilities Engaging in Human Stem Cell and Cell-Based or Cellular Therapies in the Philippines which was released by Health Secretary Enrique T. Ona on March 18, 2013. As with any new technology there is a need to regulate stem cell treatment in order to protect the public from unscrupulous people who might not be properly trained and authorized to conduct the procedure, he said. Daba said they have received reports that even here in the region, there are facilities including hospitals and clinics conducting the stem cell therapy. However, he added, they still have to verify those reports through the conduct of the surveillance. As of now all we can … Continue reading →

Kevin Rudd pledged $125 million for stem cell research. Regenerative medicine researcher Associate Professor Ernst Wolvetang explains the science and what the investment could mean. What does $125 million in funding for regenerative medicine researchpledged by Prime Minister Kevin Rudd yesterdaybuy you? Regenerative medicine is an umbrella term for therapies that involve either the delivery of stem cells to a damaged or diseased tissue or the enhancement of endogenous (stem cell mediated) repair mechanisms of the body. Its not a novel concept; a bone marrow transfer is a tried-and-tested stem cell therapy, transplanting and replacing blood cell-forming stem cells from one individual to the bone marrow of another. Mesenchymal stem cells can be isolated from a variety of tissues such as blood, fat or placenta and have the ability to generate cartilage, fat and bone. These stem cells can home to sites of injury, have immune system-dampening properties (allowing transplantation from one donor into an unrelated person) and excrete factors that promote blood vessel formation. Because of these properties it can benefit the recovery of patients after a heart attack or other ailments. Australian company Mesoblast has been successfully developing and marketing this stem cell product. Embryonic stem cells are … Continue reading →

CARLSBAD, CA--(Marketwired - Aug 21, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell-based therapies, announced today that it has entered into a master clinical research agreement with Duke University to conduct clinical trials research in Parkinson's disease using ISCO's innovative neural stem cell product. Mark Stacy, M.D., Vice Dean for Clinical Research, Neurology at Duke University School of Medicine and an internationally recognized leader in the field of Movement Disorders, including Parkinson's disease, will be the study's principal investigator. The research will be coordinated by the Duke Clinical Research Institute (DCRI), the world's largest academic clinical research organization, which is internationally recognized for conducting groundbreaking clinical trials. "We are pleased to have the opportunity to conduct the clinical trials related to ISCO's investigational stem cell therapy in Parkinson's disease patients," said Stacy. "Duke has an exceptional clinical trials team and we look forward to characterizing and understanding the safety and efficacy profile of this agent in the clinical trials setting." "We're tremendously excited to be working with such a world-class clinical research organization as Duke University," commented Dr. Ruslan Semechkin, Vice President of Research and Development at International Stem Cell Corporation. … Continue reading →

BIND Therapeutics, a Cambridge nanomedicine company developing programmable drugs, said Monday that it has dosed the first patient in a Phase 2 clinical trial of BIND-014 as a second-line therapy in patients with non-small cell lung cancer. The company is using a nano-engineering platform to develop Accurins, programmable therapeutics designed to target specific cells or tissues and concentrate a drug payload at the site of disease. The thinking is that this approach will enhance the effectiveness of the treatment while minimizing adverse effects on healthy tissues. BIND-014 represents the first Accurin nanomedicine to reach the clinic from the companys Medicinal Nanoengineering platform, the company said in a press release. In pre-clinical studies, BIND said it has been able to demonstrate that Accurins can improve tumor growth suppression and achieve higher concentrations of the payload in tumors compared to the payload administered in conventional form. In a statement, BIND chief medical officer Gregory Berk, MD, said: There are limited options for patients with advanced non-small cell lung cancer in the second-line setting. We are pleased our Phase 1 trial of BIND-014 established the safety profile and appropriate Phase 2 dose for this drug candidate, and we are advancing BIND-014 into Phase … Continue reading →

Corky struts his stuff after stem cell treatment success. One week ago, brave Corky came to Australind Veterinary Hospital to undergo revolutionary Stem Cell treatment. Today he is running, jumping and scratching. H... By: AustralindVet … Continue reading →

Press Release August 19, 2013 PROBE STEM CELL PRACTICE -- KOKO Senator Aquilino "Koko" Pimentel III, PDP Laban President, has filed a resolution seeking an inquiry into the conduct of stem cell procedures in the Philippines, with the view of having the practice regulated to ensure the protection of the health and welfare of our people. Pimentel filed the resolution amidst growing concerns over the reported proliferation of stem cell procedures being conducted in the country. Worse, Pimentel noted, stem cell procedures are reported to be performed by unaccredited foreign doctors in five-star hotels. Pimentel warned these uncontrolled practices are not only posing serious safety issues to unknowing clients, but also claiming the lives of our people. He emphasized, it is the duty of Congress to protect and uphold the right to health, and especially the right to life of our people. He cited the state policy, as declared in Article 2, Section 15 of the Constitution, to protect and promote the right to health of the people. Stem Cell Therapy (the "Procedure") is a type of intervention strategy that introduces adult stem cells into damaged tissues to be able to treat a disease or injury. The Procedure has been … Continue reading →